Zachary Klinger, DO
Interventional Pain Medicine · Corbin, KYNPI 1831620319
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Abbott at 40.7% of the total. Reporting peaked in 2022 at $3,627 and has fallen 96.8% since, to $115 in 2025. Among interventional pain medicine clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $101.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$4K
- Nevro Corp.$1K
- Boston Scientific$566
- Relievant Medsystems, Inc.$388
- Stryker$61
- plus $154 from 6 others
What the payments were for
- Travel & lodging$6,07860%
- Food & beverage$4,06540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 32 | $4,125 |
| Medtronic | 33 | $3,633 |
| Nevro Corp. | 15 | $1,217 |
| Boston Scientific | 10 | $566 |
| Relievant Medsystems, Inc. | 2 | $388 |
| Stryker | 2 | $61 |
| Painteq LLC | 1 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Vertos Medical, Inc. | 1 | $22 |
| AbbVie | 1 | $20 |
| Si-bone, Inc. | 1 | $16 |
| Globus Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,728
- Intracept$1,840
- SYNCHROMEDII$1,744
- RESTORE$924
- Proclaim IPG$545
- Senza$543
- Omnia$414
How this compares
$10,143 in reported general payments places this provider in the 90th percentile of 55 interventional pain medicine providers in Kentucky.
See all interventional pain medicine providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 793 | $14,878 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 421 | $12,042 |
| Pregabalin | 65 | $3,403 |
| Gabapentin | 219 | $2,070 |
| Oxycodone Hcl | 72 | $1,419 |
| Meloxicam | 12 | $391 |
| Tramadol Hcl | 69 | $376 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $285 |
| Tizanidine Hcl | 20 | $214 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Corbin
- Robert KlickovichFlorence$57K
- Hammad MalikRichmond$35K
- Michael FletcherFlorence$18K
- Vishal BansalMadisonville$13K
- Anand ModaduguLexington$12K
- Nathan LambornLouisville$10K
- Brock MarrsLexington$9K
- Brandon SuttonLouisville$9K
- Gary ReasorLouisville$9K
- Sai GuttiPikeville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.